Memantine vs placebo
Secondary outcome measure: cognitive abilities at the end of · people with Down syndrome
1 finding from 1 review
- Pharmacological interventions for cognitive decline in people with Down syndrome 2015 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 184 participantsLow